IGIV Study for Chronic ITP Patients Ages 3-70
NCT00511147
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
64
Enrollment
INDUSTRY
Sponsor class
Conditions
Idiopathic Thrombocytopenic Purpura
Interventions
BIOLOGICAL:
IGIV3I Grifols 10%
Sponsor
Grifols Biologicals, LLC
Collaborators
[object Object]